Associated Papers
Hypertrophic cardiomyopathy in MYBPC3 carriers in aging.
Ananthamohan K et al.
The Journal of Cardiovascular Aging, 2024
Burden of Recurrent and Ancestral Mutations in Families With Hypertrophic Cardiomyopathy.
Ross SB et al.
Circulation. Cardiovascular Genetics, 2017
Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology.
Carrier L et al.
Gene, 2015
A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
Calore C et al.
Journal of Medical Genetics, 2015
Two founder mutations in the alpha-tropomyosin and the cardiac myosin-binding protein C genes are common causes of hypertrophic cardiomyopathy in the Finnish population.
Jääskeläinen P et al.
Annals of Medicine, 2013
Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.
Page SP et al.
Circulation. Cardiovascular Genetics, 2012
Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3.
Oliva-Sandoval MJ et al.
Heart (british Cardiac Society), 2010
A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy.
Hirota T et al.
Journal of Cardiology, 2010
Are longitudinal, natural history studies the next step in genotype-phenotype translational genomics in hypertrophic cardiomyopathy?
Ackerman MJ et al.
Journal of the American College of Cardiology, 2005
Select a paper to view details